Table 2.
Gene names, gene descriptions, and significance analysis results of mapped genes in focal adhesion pathway obtained via SAM analysis, where “[ ]” showed upregulated (+) or downregulated (−) by rCFES treatment at q-value <5%.
No. | Gene | Gene Description | q-value |
---|---|---|---|
1 | SHC3 | SHC transforming protein 3 | 0.0000 [+] |
2 | ACTN2 | Actinin, alpha 2 | 0.0068 [+] |
3 | BIRC3 | Baculoviral IAP repeat-containing 3 | 0.0211 [+] |
4 | SPP1 | Secreted phosphoprotein 1 | 0.0211 [+] |
5 | AF086032 | Protein phosphatase 1, regulatory (inhibitor) subunit 12A | 0.0278 [+] |
6 | KDR | Kinase insert domain receptor | 0.0278 [+] |
7 | DDI1 | DDI1, DNA-damage inducible 1,homolog 1 (S. cerevisiae) | 0.0278 [+] |
8 | ACTB | Actin, beta | 0.0000 [−] |
9 | FLNA | Filamin A, alpha (actin binding protein 280) | 0.0000 [−] |
10 | ACTG1 | Actin, gamma 1 | 0.0000 [−] |
11 | CAV1 | Caveolin 1, caveolae protein, 22kDa | 0.0000 [−] |
12 | ITGB1 | Integrin, beta 1 | 0.0000 [−] |
13 | ITGA6 | Integrin, alpha 6 | 0.0000 [−] |
14 | COL1A2 | Collagen, type I, alpha 2 | 0.0000 [−] |
15 | CAPN2 | Calpain 2, (m/II) large subunit | 0.0000 [−] |
16 | AKT1 | V-akt murine thymoma viral oncogene homolog 1 | 0.0010 [−] |
17 | TNXB | Tenascin XB | 0.0010 [−] |
18 | ITGA5 | Integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.0010 [−] |
19 | RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.0014 [−] |
20 | ITGA8 | Integrin, alpha 8 | 0.0014 [−] |
21 | ITGA4 | Integrin, alpha 4 | 0.0014 [−] |
22 | PIK3R3 | Phosphoinositide-3-kinase,regulatory subunit 3 (p55, gamma) | 0.0014 [−] |
23 | FN1 | Fibronectin 1 | 0.0014 [−] |
24 | LAMA4 | Laminin, alpha 4 | 0.0016 [−] |
25 | THBS1 | Thrombospondin 1 | 0.0016 [−] |
26 | IGF1R | Insulin-like growth factor 1 receptor | 0.0016 [−] |
27 | COL1A1 | Collagen, type I, alpha 1 | 0.0016 [−] |
28 | CCND1 | Cyclin D1 | 0.0016 [−] |
29 | MET | Met proto-oncogene (hepatocyte growth factor receptor) | 0.0016 [−] |
30 | ACTN4 | Actinin, alpha 4 | 0.0019 [−] |
31 | AK025363 | Parvin, alpha | 0.0019 [−] |
32 | AKT2 | V-akt murine thymoma viral oncogene homolog 2 | 0.0019 [−] |
33 | CAV2 | Caveolin 2 | 0.0027 [−] |
34 | VCL | Vinculin | 0.0027 [−] |
35 | ZYX | Zyxin | 0.0027 [−] |
36 | TNC | Tenascin C (hexabrachion) | 0.0027 [−] |
37 | ACTN3 | Actinin, alpha 3 | 0.0028 [−] |
38 | VASP | Vasodilator-stimulated phosphoprotein | 0.0028 [−] |
39 | COL5A1 | Collagen, type V, alpha 1 | 0.0028 [−] |
40 | VEGFC | Vascular endothelial growth factor C | 0.0039 [−] |
41 | FAK | Focal adhesion kinase | 0.0047 [−] |
42 | PARVB | Parvin, beta | 0.0047 [−] |
43 | COL4A6 | Collagen, type IV, alpha 6 | 0.0047 [−] |
44 | LAMA5 | Laminin, alpha 5 | 0.0068 [−] |
45 | MAPK1 | Mitogen-activated protein kinase 1 | 0.0088 [−] |
46 | AK025363 | Parvin, alpha | 0.0019 [−] |
47 | THBS4 | Thrombospondin 4 | 0.0116 [−] |
48 | ERBB2 | V-erb-b2 erythroblastic leukemiaviral oncogene homolog 2 | 0.0157 [−] |
49 | AF207599 | Homo sapiens pRb-interacting protein RbBP-36 mRNA | 0.0157 [−] |
50 | DOCK1 | Dedicator of cytokinesis 1 | 0.0157 [−] |
51 | COL5A2 | Collagen, type V, alpha 2 | 0.0211 [−] |
52 | PIK3R5 | Phosphoinositide-3-kinase, regulatory subunit 5, p101 | 0.0211 [−] |
53 | ITGAV | Integrin, alpha V | 0.0211 [−] |
54 | LAMA2 | Laminin, alpha 2 | 0.0278 [−] |
55 | ARHGAP5 | Rho GTPase activating protein 5 | 0.0278 [−] |
56 | VAV2 | Vav 2 oncogene | 0.0278 [−] |
57 | CAV3 | Caveolin 3 | 0.0278 [−] |
58 | BCAR1 | Breast cancer anti-estrogen resistance 1 | 0.0369 [−] |
59 | EGFR | Epidermal growth factor receptor | 0.0369 [−] |
60 | MAPK9 | Mitogen-activated protein kinase 9 | 0.0369 [−] |
61 | AA599881 | Platelet-derived growth factor receptor, alpha polypeptide | 0.0474 [−] |
62 | THBS1 | Thrombospondin 1 | 0.0016 [−] |
63 | GRB2 | Growth factor receptor-bound protein 2 | 0.0474 [−] |
64 | LAMA3 | Laminin, alpha 3 | 0.0474 [−] |
65 | CRKL | V-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.0474 [−] |